Jump to content

Recommended Posts

"The past years have seen lots of new drugs and developments.  This year there has been a pause whilst working out issues of cross resistance and trying to figure out the differences between abiraterone and enzalutamide."


Click on this link to view a video of the highlights from the sessions on prostate cancer at ASCO 2016.


Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...